< Back to previous page
Researcher
Steven Joniau
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
1 - 10 of 17
- The role of stromal components in urothelial cancerFrom4 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- New insights in the genomic architecture and treatment of high risk and oligometastatic prostate cancerFrom10 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE)From24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Classical and non-classical actions of androgens and their receptorFrom1 Oct 2019 → TodayFunding: BOF - projects, IOF - technology concept exploration
- Fellowship: Optimization patient treatment pathway by combining genotypic and phenotypic data.From17 Dec 2018 → 16 Dec 2019Funding: Private funding of national origin - undefined
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 30 Sep 2021Funding: FWO fellowships
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better stratification of intermediate- and high-risk non-muscle-invasive bladder cancer patientsFrom1 Sep 2016 → 1 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potentialFrom1 Aug 2016 → 29 Apr 2022Funding: Private funding of national origin - undefined, BOF - doctoral mandates
- Role of hydroxymethylation as an epigenetic mark in prostate cancer biologyFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project
Publications
1 - 10 of 509
- Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potential(2022)
Authors: Lisa Moris, Frank Claessens, Steven Joniau
- Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer.(2022)
Authors: Lisa Moris, Diether Lambrechts, Christine Helsen, Bart Ghesquière, Stefaan Soenen, Roy Eerlings, Sarah El Kharraz, Hendrik Van Poppel, Steven Joniau, Frank Claessens
Pages: 527 - 541 - Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status(2022)
Authors: Steven Joniau
Number of pages: 12 - Re: Molecular Features of Exceptional Response to Neoadjuvant Anti-androgen Therapy in High-risk Localized Prostate Cancer.(2022)
Authors: Frank Claessens, Steven Joniau
Pages: 314 - Radium-223 in patients with prostate specific antigen (PSA) progression and without clinical metastases following maximal local therapy: A pilot study.(2022)
Authors: Lorenzo Tosco, Gaëtan Devos, Laura Schillebeeckx, Steven Pans, Karolien Goffin, Wouter Everaerts, Hendrik Van Poppel, Steven Joniau
Pages: 7.e9 - 7.e17 - Molecular Subtypes and Gene Expression Signatures as Prognostic Features in Fully Resected Clear Cell Renal Cell Carcinoma: A Tailored Approach to Adjuvant Trials(2021)
Authors: Eduard Roussel, Lisa Kinget, Bram Boeckx, Marcella Baldewijns, Hendrik Van Poppel, Steven Joniau, Diether Lambrechts, Maarten Albersen, Benoit Beuselinck
Pages: 1 - 13 - Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison(2021)
Authors: Steven Joniau
Pages: 518 - 531Number of pages: 14 - A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE(2021)
Authors: Steven Joniau
Pages: 837 - 846Number of pages: 10 - Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series(2021)
Authors: Steven Joniau
Pages: 1184 - 1191Number of pages: 8 - Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?(2021)
Authors: Charlien Berghen, Gert De Meerleer, Steven Joniau